HER-2/neu 369-377 (HLA-A*02:01)

HER-2/neu 369-377 (HLA-A*02:01)
€57.50 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP07858_1
KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase... more
Product information "HER-2/neu 369-377 (HLA-A*02:01)"

KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase erbB-2 from Rattus norvegicus (brown rat) and Receptor tyrosine-protein kinase erbB-2 from Homo sapiens (human).ï¾  This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays HER-2/neu 369-377 peptide KIFGSLAFL (HLA-A*02:01) for stimulation of T-cells. Single peptide (KIFGSLAFL) for stimulation of human Her-2/neu-specific CD8+ T-cells.

Available downloads:

 
Sequence:KIFGSLAFL
Gene:ERBB2
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Receptor tyrosine-protein kinase erbB-2
Species:Human
Allele:HLA-A*02:01
Application :T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication :Cancer
P60 217-225 (H-2Kd) P60 217-225 (H-2Kd)
From €57.50 *
PAP 299-307 PAP 299-307
From €57.50 *
[beta]-Amyloid (1-28) [beta]-Amyloid (1-28)
From €172.50 *
Arg9 Arg9
From €57.50 *
MOG 35-55 MOG 35-55
From €115.00 *
Viewed